Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
about
The Migraine-Stroke ConnectionImpact of valvular thickness on stroke recurrence in medically treated patients with strokeClusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis.Association of annular calcification and aortic valve sclerosis with brain findings on magnetic resonance imaging in community dwelling older adults: the cardiovascular health studyNonorgan specific autoantibodies and heart damage.Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.Environment and lupus-related diseases.Valvular heart disease in antiphospholipid syndrome.Transient ischemic attack and stroke in systemic lupus erythematosus.Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome.Immune-Mediated Heart Disease.Atherosclerosis in primary antiphospholipid syndrome.Neurological presentations of the antiphospholipid syndrome: three illustrative cases.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome.Cardiac valve vegetations in APS, role of long-term anticoagulation
P2860
Q26747260-01C39BC9-B5EF-44AA-BDC3-C3E7D5F4A0DDQ28221124-4CB3AA36-AC06-42BD-AE47-7A06E85298F4Q33374901-08B043F9-264D-41D2-BB54-2B9BE6662F41Q33922549-8C2AD249-A207-4A8A-AC6D-CBF584F8BFB6Q36283415-F03E9977-C655-4BEB-849B-32D6A704B9B8Q36596375-286C6CF5-2CA3-4240-AEBF-82A4C62A7697Q37385436-918ABA51-6CF0-4012-AB62-3166CF6A3E6DQ37953846-918A0C90-90F5-4983-B6FC-B22C66EED6A2Q38086166-B3179069-A938-4836-90F2-B1B169AB6AC8Q38149851-E72B4570-952B-4B06-AED0-86F4AB2D3B81Q38753510-A4FDB6AE-A7A3-4F02-920E-126EEA73158BQ42130326-C6FB9F08-9CA0-464A-8A3A-0D09EFAE287CQ51835838-41F15750-945C-4BB0-AACA-743953BB5900Q52852275-794B3D5B-1B42-47E0-88CA-96D9F81C3607Q53096115-3084AAE8-3F63-4C9A-A6EF-B48F4EED5060Q53159273-D66F3BC6-7C9C-4028-AF09-89DED276ECD8Q55440072-DBFBAB97-015F-4F80-9DF8-B6FBAEF50F62Q58895864-A1473958-5A0E-4C3F-B55D-1E0C12877435
P2860
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Close association between valv ...... the antiphospholipid syndrome
@ast
Close association between valv ...... the antiphospholipid syndrome
@en
type
label
Close association between valv ...... the antiphospholipid syndrome
@ast
Close association between valv ...... the antiphospholipid syndrome
@en
prefLabel
Close association between valv ...... the antiphospholipid syndrome
@ast
Close association between valv ...... the antiphospholipid syndrome
@en
P2093
P2860
P50
P356
P1476
Close association between valv ...... the antiphospholipid syndrome
@en
P2093
P2860
P304
P356
10.1136/ARD.2004.032813
P407
P577
2005-03-18T00:00:00Z